Canada markets open in 1 hour 41 minutes

OpGen, Inc. (OPGN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.5350+0.0201 (+3.90%)
At close: 04:00PM EDT
0.5453 +0.01 (+1.93%)
After hours: 05:34PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.5149
Open0.4995
Bid0.4943 x 100
Ask0.5592 x 100
Day's Range0.4940 - 0.5390
52 Week Range0.1650 - 3.8400
Volume169,744
Avg. Volume1,738,267
Market Cap6.428M
Beta (5Y Monthly)-0.69
PE Ratio (TTM)N/A
EPS (TTM)-6.2500
Earnings DateApr 30, 2024 - May 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    OpGen Provides Update on Business Operations and Strategic Opportunities

    ROCKVILLE, Md., April 29, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it entered into an agreement to sell its commercial customer contracts and installed base of Unyvero systems to Camtech Pte Ltd (“Camtech”), a Singaporean family office for $218,000. The transaction follows Camtech’s prior acquisition of all of Curetis GmhH’s (“Curetis”), the Company’s subsidiary, Unyvero assets, rights and businesses, as part of Curetis’ insolvency procee

  • GlobeNewswire

    OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K

    ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company not filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all periodic reports with th

  • GlobeNewswire

    OpGen Announces Acquisition of Preferred Stock by David Lazar

    David Lazar invests $3 million in Preferred StockNew OpGen Board of Directors appointedDavid Lazar will take over as CEO of OpGenOpGen settles outstanding liabilities with EIB ROCKVILLE, Md., March 25, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), announced today that the Company entered into a securities purchase agreement with David E. Lazar, an experienced private investor, pursuant to which he will acquire 3,000,000 shares of Series E Convertible Preferred St